Automatic referral to cardiac rehabilitation

Sherry L Grace1, Alexandra Evindar, Tabitha N Kung

  • 1University Health Network Women's Health Program, Toronto, Ontario, Canada. sherry.grace@uhn.on.ca

Medical Care
|June 24, 2004
PubMed

Insights

Cardiac rehabilitation (CR) enrollment is predicted by fewer barriers and perceived need, not patient demographics, when using automatic referrals. This highlights the importance of addressing logistical challenges and patient perceptions for better access to cardiac care.

Area of Science:

  • Cardiology
  • Health Services Research
  • Behavioral Science

Background:

  • Cardiac rehabilitation (CR) is underutilized, especially among women and minorities.
  • Automatic referral systems aim to improve CR access.
  • The Behavioral Model of Health Services Utilization provides a framework for understanding healthcare access.

Purpose of the Study:

  • To examine factors influencing CR enrollment within an automatic referral system.
  • To test the hypothesis that enabling and perceived need factors predict enrollment, while predisposing factors do not.

Main Methods:

  • Retrospective chart review and survey of atherosclerotic heart disease (AHD) patients (n=501) at a tertiary care center.
  • Survey assessed sociodemographics, CR barriers/facilitators, exercise beliefs, social support, and illness perceptions.
  • Statistical analysis to identify predictors of CR enrollment.

Main Results:

  • 73.2% of referred patients (n=272) attended a CR assessment.
  • Lower denial/minimization, fewer logistical barriers (distance, cost), and lower perceptions of AHD as episodic predicted CR enrollment.
  • Predisposing factors (sociodemographics) were not significant predictors.

Conclusions:

  • Enabling factors and perceived need significantly predict CR enrollment in an automatic referral model.
  • Predisposing factors do not appear to influence enrollment within this system.
  • Further prospective studies evaluating automatic referral for CR are recommended.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...